Signant SmartSignals GxP Inventory Solution Enhances Clinical Supply Chain for Biotech Firm

A pharmaceutical and biotechnology company headquartered in Japan was reportedly relying on an interconnected web of internal divisions, external vendors, and collaborators to create and distribute pharmaceuticals for their research and developmental endeavors centered around four primary therapeutic domains.

In an effort to streamline their worldwide study-related supply chain processes, the firm utilized Signant SmartSignals GxP Inventory. The cloud-based GxP Inventory platform consolidated supply production, quality monitoring, logistics, and distribution within a unified system, replacing an intricate system involving disconnected spreadsheets, paper batch records, and emails.

Access the case study below to discover how the simplification and digitization of clinical supply chain operations enhanced transparency, lowered risks and expenses, and optimized efficiency.